We are live on ! Find out more
NIM

NEOS Investment Management Portfolio holdings

AUM $27.1B
1-Year Est. Return 57.21%
This Fund
S&P 500
This Quarter Est. Return
+6.42%
1 Year Est. Return
+57.21%
3 Year Est. Return
+163.05%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$2.43B
AUM Growth
+$814M
Cap. Flow
+$708M
Cap. Flow %
29.14%
Top 10 Hldgs %
36.44%
Holding
590
New
24
Increased
504
Reduced
11
Closed
21

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$45.8M
2
AAPL icon
Apple
AAPL
+$39.2M
3
NVDA icon
NVIDIA
NVDA
+$34.5M
4
AMZN icon
Amazon
AMZN
+$23.5M
5
META icon
Meta Platforms (Facebook)
META
+$18.4M

Top Sells

Rank Stock Value
1
SWAV
Shockwave Medical, Inc. Common Stock
SWAV
+$1.85M
2
PXD
Pioneer Natural Resource Co.
PXD
+$1.33M
3
OMCL icon
Omnicell
OMCL
+$903K
4
LECO icon
Lincoln Electric
LECO
+$596K
5
SIRI icon
SiriusXM
SIRI
+$495K

Sector Composition

Rank Sector Weight
1 Technology 36.52%
2 Healthcare 13.99%
3 Communication Services 10.54%
4 Consumer Discretionary 9.76%
5 Financials 7.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HIG icon
326
Hartford Financial Services
HIG
$36.9B
$1.01M 0.04%
10,004
+2,988
+43% +$300K
KROS icon
327
Keros Therapeutics
KROS
$217M
$1M 0.04%
21,904
+7,640
+54% +$411K
HPE icon
328
Hewlett Packard
HPE
$76.2B
$992K 0.04%
46,860
+14,940
+47% +$275K
VTWO icon
329
Vanguard Russell 2000 ETF
VTWO
$16.9B
$992K 0.04%
+12,100
New +$989K
LEGN icon
330
Legend Biotech
LEGN
$3.32B
$992K 0.04%
22,392
+15,310
+216% +$706K
TDG icon
331
TransDigm Group
TDG
$60.9B
$985K 0.04%
771
– –
XYL icon
332
Xylem
XYL
$25.3B
$980K 0.04%
7,228
+1,992
+38% +$271K
GMAB icon
333
Genmab
GMAB
$21.2B
$969K 0.04%
38,554
+26,246
+213% +$744K
CRSP icon
334
CRISPR Therapeutics
CRSP
$5.11B
$969K 0.04%
17,936
+10,450
+140% +$604K
EIX icon
335
Edison International
EIX
$21.3B
$940K 0.04%
13,089
+3,984
+44% +$289K
AGIO icon
336
Agios Pharmaceuticals
AGIO
$2B
$938K 0.04%
21,745
+12,021
+124% +$434K
FTV icon
337
Fortive
FTV
$16.8B
$937K 0.04%
16,775
+5,287
+46% +$307K
AKRO
338
DELISTED
Akero Therapeutics
AKRO
$933K 0.04%
39,754
+8,225
+26% +$176K
TSCO icon
339
Tractor Supply
TSCO
$17.6B
$927K 0.04%
17,170
+4,980
+41% +$268K
TER icon
340
Teradyne
TER
$53.9B
$926K 0.04%
6,245
+2,846
+84% +$361K
DG icon
341
Dollar General
DG
$27.7B
$917K 0.04%
6,934
+1,992
+40% +$278K
GPN icon
342
Global Payments
GPN
$23.2B
$912K 0.04%
9,429
+2,988
+46% +$329K
FITB
343
Fifth Third Bancorp
FITB
$48.7B
$911K 0.04%
24,978
+7,968
+47% +$291K
COR icon
344
Cencora
COR
$61.2B
$907K 0.04%
4,024
+996
+33% +$231K
VKTX icon
345
Viking Therapeutics
VKTX
$3.53B
$906K 0.04%
17,083
+2,271
+15% +$149K
TRGP icon
346
Targa Resources
TRGP
$61.7B
$900K 0.04%
6,986
+1,992
+40% +$233K
CBRE icon
347
CBRE Group
CBRE
$41.3B
$894K 0.04%
10,038
+2,988
+42% +$265K
DAWN
348
DELISTED
Day One Biopharmaceuticals
DAWN
$894K 0.04%
64,853
+20,430
+46% +$299K
PPG icon
349
PPG Industries
PPG
$23.6B
$891K 0.04%
7,076
+1,992
+39% +$264K
WTW icon
350
Willis Towers Watson
WTW
$29.3B
$884K 0.04%
3,374
+996
+42% +$257K
12 13
14
15 16

Similar funds

RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
Los Angeles Capital Management
Los Angeles Capital Management Los Angeles, California $27.2B AUM 43.16% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return
RCMU
Rokos Capital Management (UK) London, United Kingdom $26.8B AUM 90.85% 1-Year Est. Return
SC
Scotia Capital Toronto, Ontario, Canada $26.8B AUM 33.07% 1-Year Est. Return
Fiera Capital (Canada)
Fiera Capital (Canada) Montreal, Quebec, Canada $27.6B AUM 23.56% 1-Year Est. Return
SO
STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return

NEOS Investment Management's Q2 2024 Portfolio in Review

As of Q2 2024, NEOS Investment Management held 590 positions worth $2.43B, up 50% from $1.61B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

NEOS Investment Management deployed $708M of net new capital in Q2 2024, opening 24 new positions and adding to 504 existing holdings. Its largest new stake was Primoris Services: 53,757 shares worth $2.68M.

By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 35% a quarter earlier, followed by Healthcare and Communication Services.

On the sell side, the largest reduction was Madrigal Pharmaceuticals, an estimated $234K trimmed.

  • NEOS Investment Management's largest Q2 2024 buy was Primoris Services: 53,757 shares worth $2.68M.
  • NEOS Investment Management added most to Microsoft in Q2 2024, an estimated $45.8M increase.
  • NEOS Investment Management's biggest Q2 2024 reduction was Madrigal Pharmaceuticals, cutting an estimated $234K.
  • NEOS Investment Management fully exited Shockwave Medical, Inc. Common Stock in Q2 2024, selling an estimated $1.85M.
  • NEOS Investment Management's ten largest holdings make up 36% of its $2.43B portfolio in Q2 2024.
  • NEOS Investment Management opened 24 new positions and closed 21 in Q2 2024.
  • NEOS Investment Management's portfolio value rose 50% quarter-over-quarter to $2.43B.

Based on NEOS Investment Management's 13F filing for Q2 2024, filed 14 Aug 2024.